AKT1 and neoplasm: This comprehensive review proposes that naturally occurring compounds act as multi-targeted regulators of PTC, with anti-tumor effects that converge on the modulation of MAPK, PI3K/Akt, and JAK/STAT, thereby identifying shared molecular regulators and translational opportunities for integrative therapeutic strategies in advanced or recurrent PTC.